These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19343773)

  • 1. Therapeutic potential of targeting haploinsufficient genes in cancer.
    Cheung KJ; Ebert BL
    Pediatr Blood Cancer; 2009 Aug; 53(2):131-2. PubMed ID: 19343773
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor suppressor genetics.
    Payne SR; Kemp CJ
    Carcinogenesis; 2005 Dec; 26(12):2031-45. PubMed ID: 16150895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two genetic hits (more or less) to cancer.
    Knudson AG
    Nat Rev Cancer; 2001 Nov; 1(2):157-62. PubMed ID: 11905807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer--a disease of the genes].
    Sauter G
    Praxis (Bern 1994); 1998 Apr; 87(16):535-7. PubMed ID: 9600016
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor suppressor genes (TSG).
    Teh BT; Larsson C; Nordenskjöld M
    Anticancer Res; 1999; 19(6A):4715-28. PubMed ID: 10697587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy: an evolving definition of a cancer cell.
    Williams JL
    Clin Lab Sci; 2002; 15(1):37-43. PubMed ID: 12778955
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic susceptibility to in vivo and in vitro chemical transformation.
    Walker C
    Prog Clin Biol Res; 1996; 395():13-22. PubMed ID: 8895980
    [No Abstract]   [Full Text] [Related]  

  • 8. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on genetic markers of cancer].
    Bénard J; Bressac-de Paillerets B
    Bull Cancer; 1998 Jan; 85(1):21-6. PubMed ID: 9752340
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super competition as a possible mechanism to pioneer precancerous fields.
    Rhiner C; Moreno E
    Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new MAFia in cancer.
    Eychène A; Rocques N; Pouponnot C
    Nat Rev Cancer; 2008 Sep; 8(9):683-93. PubMed ID: 19143053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder carcinogenesis, in search of clues and genes.
    Bangma C; Jenster G
    Eur Urol; 2006 Aug; 50(2):205-7. PubMed ID: 16530924
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular origins of cancer.
    Burstein HJ; Schwartz RS
    N Engl J Med; 2008 Jan; 358(5):527. PubMed ID: 18234758
    [No Abstract]   [Full Text] [Related]  

  • 15. WWOX, the tumour suppressor gene affected in multiple cancers.
    Lewandowska U; Zelazowski M; Seta K; Byczewska M; Pluciennik E; Bednarek AK
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():47-56. PubMed ID: 19609013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic prevention of cancer].
    Hasle H; Schiøtz PO
    Ugeskr Laeger; 2000 May; 162(19):2759. PubMed ID: 10827548
    [No Abstract]   [Full Text] [Related]  

  • 17. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The state of oncology at the end of the 20th century. Results--unknowns--perspectives].
    García García G
    An R Acad Nac Med (Madr); 1993; 110(3):377-86. PubMed ID: 8116868
    [No Abstract]   [Full Text] [Related]  

  • 19. The new millennium: applying novel technology to the study of the cancer cell in situ.
    Brown MR; Kohn EC; Hutter RV
    Cancer; 2000 Jan; 88(1):2-5. PubMed ID: 10618599
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic and cellular mechanisms of oncogenesis.
    Downward J; Hahn WC
    Curr Opin Genet Dev; 2009 Feb; 19(1):1-3. PubMed ID: 19208465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.